Arcutis Biotherapeutics Inc (ARQT)
8.86
-0.30
(-3.28%)
USD |
NASDAQ |
May 28, 16:00
8.91
+0.05
(+0.56%)
After-Hours: 20:00
Arcutis Biotherapeutics Total Long Term Debt (Quarterly): 202.80M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 202.80M |
December 31, 2023 | 201.80M |
September 30, 2023 | 200.78M |
June 30, 2023 | 199.77M |
Date | Value |
---|---|
March 31, 2023 | 198.76M |
December 31, 2022 | 197.77M |
September 30, 2022 | 196.75M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
196.75M
Minimum
Sep 2022
202.80M
Maximum
Mar 2024
199.78M
Average
199.77M
Median
Jun 2023
Total Long Term Debt (Quarterly) Benchmarks
Marinus Pharmaceuticals Inc | 73.47M |
AdaptHealth Corp | 2.199B |
Pfizer Inc | 68.71B |
Heron Therapeutics Inc | 173.99M |
Adverum Biotechnologies Inc | -- |